Endoscopic sleeve gastroplasty (ESG) for morbid obesity: how effective is it?
Bariatric endoscopy
Endoscopic sleeve gastroplasty
Morbid obesity
Obesity
Overstitch
Weight loss
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
30
09
2020
accepted:
05
01
2021
pubmed:
26
1
2021
medline:
3
3
2022
entrez:
25
1
2021
Statut:
ppublish
Résumé
ESG is an effective treatment for classes I and II obesity. However, the benefit of ESG in patients with morbid obesity (BMI ≥ 40 kg/m We reviewed 484 patient records and identified 435 patients (class I: 105, class II: 169, class III: 161) who underwent ESG at our unit between May 2013 and March 2020. We compared their total body weight loss (%TBWL) and safety over 1 year. We used a linear mixed model (LMM) to analyse repeated measures of weight loss outcomes at 3, 6, 9, and 12 months for comparison between the three BMI groups. Among the 435 patients, 396 patients (class I: 99, class II: 151, class III: 146) completed 6 months, and 211 patients reached 1 year (class I: 50, class II: 77, class III: 84). There was no difference in age between the groups. In LMM analysis, adjusting for age and sex, we found ESG had a significantly higher TBWL, %TBWL, and BMI decline in class III compared to classes I and -II obesity at all time points (p < 0.001). The adjusted mean %TBWL at 1 year with classes I, -II, and -III obesity was 16.5%, 18.2%, and 20.5%, respectively. The overall complication rate and the hospital stay was identical in the three groups. ESG induced significant weight loss in all classes of obesity. In class III obesity, the weight loss achieved was significantly higher at 1 year. In patients declining or unsuitable for surgery, ESG could be considered as an alternative treatment option.
Identifiants
pubmed: 33492503
doi: 10.1007/s00464-021-08289-1
pii: 10.1007/s00464-021-08289-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
352-360Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
Références
Ray GA, Kim KK, Wilding JPH, World Obesity Federation (2017) Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 18(7):715–723
doi: 10.1111/obr.12551
Hall KD, Kahan S (2018) Maintenance of lost weight and long-term management of obesity. Med Clin N Am 102(1):183–197
doi: 10.1016/j.mcna.2017.08.012
Wyatt HR (2013) Update on treatment strategies for obesity. J Clin Endocrinol Metab 98(4):1299–1306
doi: 10.1210/jc.2012-3115
Aune D, Sen A, Prasad M et al (2016) BMI and all cause mortality: systematic review and non-linear dose–response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 353:i2156
doi: 10.1136/bmj.i2156
Busutil R, Espallardo O, Torres A, Martínez-Galdeano L, Zozaya N, Hidalgo-Vega Á (2017) The impact of obesity on health-related quality of life in Spain. Health Qual Life Outcomes 15(1):197
doi: 10.1186/s12955-017-0773-y
Angrisani L, Santonicola A, Iovino P et al (2018) IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg 28(12):3783–3794
doi: 10.1007/s11695-018-3450-2
Himpens J, Ramos A, Welbourn R, Kinsman R, Walton P (2018) Fourth IFSO Global Registry Report 2018. Dendrite Clinical Systems Ltd, Henley-on- Thames
Lopez-Nava G, Asokkumar R (2019) Step-by-step approach to endoscopic gastroplasty by a novel single-channel endoscopic suturing system. VideoGIE 4(10):444–446
doi: 10.1016/j.vgie.2019.06.008
Lopez-Nava G, Sharaiha RZ, Vargas EJ et al (2017) Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 27(10):2649–2655
doi: 10.1007/s11695-017-2693-7
Mohan BP, Asokkumar R, Khan SR et al (2020) Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis. Endosc Int Open 8(4):E558–E565
doi: 10.1055/a-1120-8350
Fiorillo C, Quero G, Vix M et al (2020) 6-Month gastrointestinal Quality of Life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg 30(5):1944–1951
doi: 10.1007/s11695-020-04419-1
Lopez-Nava G, Galvão MP, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP (2015) Endoscopic sleeve gastroplasty: how I do it? Obes Surg 25(8):1534–1538
doi: 10.1007/s11695-015-1714-7
Grupo Colaborativo de la Sociedad Española de Nutrición Comunitaria (SENC), Aranceta Bartrina J, Arija Val V et al (2016) Dietary guidelines for the Spanish population (SENC, December 2016); the new graphic icon of healthy nutrition. Nutr Hosp 33:1–48
Bariatric Endoscopy Task Force SGE, Technology Committee ASGE, Abu Dayyeh BK, Kumar N et al (2015) ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82(3):425-438.e5
doi: 10.1016/j.gie.2015.03.1964
García-García ML, Martín-Lorenzo JG, Lirón-Ruiz R et al (2017) Perioperative complications following bariatric surgery according to the Clavien-Dindo classification. Score validation, literature review and results in a single-centre series. Surg Obes Relat Dis 13:1555–1561
doi: 10.1016/j.soard.2017.04.018
Lopez-Nava G, Asokkumar R, Ielpo B, Bautista I, Vicente E (2019) Biliary peritonitis after endoscopic sutured gastroplasty for morbid obesity (with video). Gastrointest Endosc 90(4):686–688
doi: 10.1016/j.gie.2019.06.002
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L (2018) Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol 6(12):944–953
doi: 10.1016/S2213-8587(18)30288-2
Ryan DH, Yockey SR (2017) Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep 6(2):187–194
doi: 10.1007/s13679-017-0262-y
Ma C, Avenell A, Bolland M et al (2017) Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 359:j4849
doi: 10.1136/bmj.j4849
Wing RR, Phelan S (2005) Long-term weight loss maintenance. Am J Clin Nutr 82(1):222S-225S
doi: 10.1093/ajcn/82.1.222S
Lopez-Nava G, Asokkumar R, Lacruz T, Rull A, Beltran L, Bautista-Castaño I (2020) The effect of weight loss and exercise on Health-Related Quality of Life (HRQOL) following Endoscopic Bariatric Therapies (EBT) for obesity. Health Qual Life Outcomes 18(1):130
doi: 10.1186/s12955-020-01359-3
Abu Dayyeh BK, Acosta A, Camilleri M et al (2017) Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 15(1):37-43.e1
doi: 10.1016/j.cgh.2015.12.030
Lopez-Nava G, Negi A, Bautista-Castaño I, Rubio MA, Asokkumar R (2020) Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). Obes Surg 30(7):2642–2651
doi: 10.1007/s11695-020-04541-0
Fayad L, Adam A, Schweitzer M et al (2019) Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc 89(4):782–788
doi: 10.1016/j.gie.2018.08.030
Lopez-Nava G, Asokkumar R, Negi A et al (2020) Re-suturing after primary endoscopic sleeve gastroplasty (ESG) for obesity. Surg Endosc. https://doi.org/10.1007/s00464-020-07666-6
doi: 10.1007/s00464-020-07666-6
pubmed: 32583068
Alqahtani AR, Elahmedi M, Alqahtani YA, Al-Darwish A (2019) Laparoscopic sleeve gastrectomy after endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. Obes Surg 29(11):3547–3552
doi: 10.1007/s11695-019-04024-x
Chen SY, Stem M, Schweitzer MA et al (2015) Assessment of postdischarge complications after bariatric surgery: A National Surgical Quality Improvement Program analysis. Surgery 158:777–786
doi: 10.1016/j.surg.2015.04.028
American Society for Metabolic and Bariatric Surgery Clinical Issues Committee (2013) ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 9(4):493–497
doi: 10.1016/j.soard.2013.03.006
Zorron R, Veltzke-Schlieker W, Adler A et al (2018) Endoscopic sleeve gastroplasty using Apollo Overstitch as a bridging procedure for superobese and high risk patients. Endoscopy 50(1):81–83
pubmed: 29041019
Saumoy M, Schneider Y, Zhou XK et al (2018) A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc 87(2):442–447
doi: 10.1016/j.gie.2017.08.014
Sharaiha RZ, Kumta NA, Saumoy M et al (2017) Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 15(4):504–510
doi: 10.1016/j.cgh.2016.12.012
Alqahtani A, Al-Darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M (2019) Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc 89(6):1132–1138
doi: 10.1016/j.gie.2018.12.012
Lopeznava G, Asokkumar R, Bautista I et al (2020) Endoscopic sleeve gastroplasty (ESG), laparoscopic sleeve gastrectomy (LSG), and laparoscopic greater curve plication (LGCP): do they differ at 2-years? Endoscopy. https://doi.org/10.1055/a-1224-7231 . Accessed 22 July 2020
doi: 10.1055/a-1224-7231
Cadena-Obando D, Ramírez-Rentería C, Ferreira-Hermosillo A et al (2020) Are there really any predictive factors for a successful weight loss after bariatric surgery? BMC Endocr Disord 20(1):20
doi: 10.1186/s12902-020-0499-4
Lopez-Nava G, Asokkumar R, Rull A, Corbelle F, Beltran L, Bautista I (2019) Bariatric endoscopy procedure type or follow-up: what predicted success at 1 year in 962 obese patients? Endosc Int Open 7(12):E1691–E1698
doi: 10.1055/a-1007-1769